Sou Hu Cai Jing·2025-10-15 08:45Core Insights - The precision medicine sector experienced a 1.97% increase on October 15, with Tsinghua Life leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - Tsinghua Life (300642) closed at 25.85, up 10.38% with a trading volume of 294,900 shares and a transaction value of 756 million [1] - Beilu Pharmaceutical (300016) closed at 8.77, up 4.78% with a trading volume of 251,800 shares and a transaction value of 26.61 million [1] - Zoli Pharmaceutical (300181) closed at 19.07, up 4.21% with a trading volume of 283,300 shares and a transaction value of 534 million [1] - WuXi AppTec (603259) closed at 99.46, up 3.69% with a trading volume of 421,800 shares and a transaction value of 4.123 billion [1] - Qianhong Pharmaceutical (002550) closed at 9.08, up 3.42% with a trading volume of 301,300 shares and a transaction value of 271 million [1] Capital Flow - The precision medicine sector saw a net inflow of 339 million from institutional investors, while retail investors experienced a net outflow of 18.88 million [2][3] - Major stocks like Zoli Pharmaceutical and Anke Bio (300009) had significant net inflows from institutional investors, with 76.71 million and 54.19 million respectively [3]